The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s DNA and gene chip market report forecasts the DNA and gene chip market size to grow to $11.71 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

Learn More On The DNA And Gene Chip Market Report 2023 – https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

DNA And Gene Chip Market Size Forecast
The global DNA and gene chip market is expected to grow from $6.47 billion in 2022 to $7.33 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The DNA and gene chip market size is expected to reach $11.71 billion in 2027 at a CAGR of 12.4%.

North America held the largest DNA and gene chip market share, and Asia-Pacific was the fastest-growing region in 2022.

Key DNA And Gene Chip Market Driver ­– Rise In Demand For Early Cancer Detection
For instance, according to the Switzerland-based non-governmental organization Union for International Cancer Control (UICC)’s GLOBOCAN 2020: New Global Cancer Data published in December 2020, there were 10.3 million cancer deaths and 19.3 million new cases worldwide in 2020. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.

Request for A Sample Of The Global DNA And Gene Chip Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

Key DNA And Gene Chip Market Trend – Strategic Partnerships And Collaborations
Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled cancer risk assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in January 2020, Illumina Inc., a US-based biotechnology company involved in DNA sequencing and array-based technologies, partnered with Roche, a Switzerland-based pharmaceuticals and diagnostics company. This partnership brings together complementary capabilities of each company to broaden the global adoption of NGS in cancer care. Roche receives rights from Illumina to create and market in-vitro diagnostic (IVD) tests on Illumina’s NextSeq 550Dx System and its future portfolio of diagnostic (Dx) sequencing systems, including the forthcoming NovaSeqDx.

DNA And Gene Chip Market Segment
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

DNA And Gene Chip Market Major Players and Strategies
Major players in the DNA and gene chip market are Perkin Elmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology, Affymetrix Inc., Bioneer Corp., and Eurofins Mwg Operon.

In October 2021, Schott Minifab, an Australia-based manufacturer of microfluidic and medical devices, acquired Applied Microarrays Inc. for an undisclosed amount. This acquisition is expected to strengthen Schott’s bioscience capabilities and expand its biosensor printing capabilities. Microarrays Inc. is a US-based DNA microarray manufacturing company that develops DNA and protein biosensors and other microarrays.

The DNA And Gene Chip Global Market Report 2023 covers regional data on DNA and gene chip market size, DNA and gene chip market trends and drivers, opportunities, strategies, and DNA and gene chip market competitor analysis. The countries covered in the DNA and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.

View More Reports Related To The DNA And Gene Chip Market –
DNA Based Skin Care Products Global Market Report 2023
Recombinant DNA Technology Global Market Report 2023 –
Gene Editing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: